Share this article
Go deeper with GlobalData
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Researchers at Columbia University Medical Centre (CUMC) identified how anti-epileptic drug Perampanel blocks AMPA receptors in the brain, and GE planned to invest €150 million in a new biopharmaceutical manufacturing campus at Ireland. Pharmaceutical-technology.com wraps up the key headlines from September.
October 6, 2016